EGLN2 and cancer: Although PHD1 has not previously been linked directly to mechanisms involved in cell transformation and cancer, PHD1 misregulation has been detected in forms of human breast, ovarian, and intestinal cancer (Jokilehto and Jaakkola, 2010).